{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:59:39Z","timestamp":1780721979275,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"DOI":"10.1007\/s11934-026-01339-y","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T02:16:04Z","timestamp":1780712164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis"],"prefix":"10.1007","volume":"27","author":[{"given":"Tal","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Ieong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justina","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"8","key":"1339_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jama.2020.26858","volume":"325","author":"MP McGinley","year":"2021","unstructured":"McGinley MP, Goldschmidt CH, Rae-Grant AD. Diagnosis and treatment of multiple sclerosis: a review. JAMA. 2021;325(8):765\u201379.","journal-title":"JAMA"},{"issue":"6","key":"1339_CR2","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1002\/nau.24687","volume":"40","author":"S Seddone","year":"2021","unstructured":"Seddone S, Marturano M, Bientinesi R, Lucchini M, Bassi P, Mirabella M, et al. Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments. Neurourol Urodyn. 2021;40(6):1500\u20138.","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"1339_CR3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.12965\/jer.2142594.297","volume":"17","author":"CL Lee","year":"2021","unstructured":"Lee CL, Lee J, Park JM, Na HS, Shin JH, Na YG, et al. Sophisticated regulation of micturition: review of basic neurourology. J Exerc Rehabil. 2021;17(5):295\u2013307.","journal-title":"J Exerc Rehabil"},{"key":"1339_CR4","unstructured":"American Urological Association. Adult neurogenic lower urinary tract dysfunction [Internet]. AUA. 2021 [cited 2025 Jul 1]. Available from: https:\/\/www.auanet.org\/guidelines-and-quality\/guidelines\/adult-neurogenic-lower-urinary-tract-dysfunction"},{"key":"1339_CR5","doi-asserted-by":"publisher","first-page":"103311","DOI":"10.1016\/j.nicl.2022.103311","volume":"37","author":"V Pongratz","year":"2023","unstructured":"Pongratz V, Bussas M, Schmidt P, Grahl S, Gasperi C, El Husseini M, et al. Lesion location across diagnostic regions in multiple sclerosis. Neuroimage Clin. 2023;37:103311.","journal-title":"Neuroimage Clin"},{"key":"1339_CR6","doi-asserted-by":"publisher","first-page":"122846","DOI":"10.1016\/j.jns.2023.122846","volume":"456","author":"D Kreiter","year":"2024","unstructured":"Kreiter D, Postma AA, Hupperts R, Gerlach O. Hallmarks of spinal cord pathology in multiple sclerosis. J Neurol Sci. 2024;456:122846.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"1339_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5489\/cuaj.4058","volume":"11","author":"SM Aharony","year":"2017","unstructured":"Aharony SM, Lam O, Corcos J. Evaluation of lower urinary tract symptoms in multiple sclerosis patients: review of the literature and current guidelines. Can Urol Assoc J. 2017;11(1\u20132):61\u20134.","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"1339_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/diagnostics12010191","volume":"12","author":"J Beck","year":"2022","unstructured":"Beck J, Jaekel AK, Zeller FL, Kowollik M, Kurze I, Kaufmann A, et al. Clinical predictors of neurogenic lower urinary tract dysfunction in persons with multiple sclerosis. Diagnostics (Basel). 2022;12(1):191.","journal-title":"Diagnostics (Basel)"},{"key":"1339_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-019-1582-1","volume":"20","author":"F Nazari","year":"2020","unstructured":"Nazari F, Shaygannejad V, Mohammadi Sichani M, Mansourian M, Hajhashemi V. The prevalence of lower urinary tract symptoms based on individual and clinical parameters in patients with multiple sclerosis. BMC Neurol. 2020;20:1\u201311.","journal-title":"BMC Neurol"},{"issue":"3","key":"1339_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/jnnp.56.3.245","volume":"56","author":"CD Betts","year":"1993","unstructured":"Betts CD, D\u2019Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1993;56(3):245\u201350.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1339_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0022-5347(01)67258-6","volume":"154","author":"EL Koldewijn","year":"1995","unstructured":"Koldewijn EL, Hommes OR, Lemmens WA, Debruyne FM, Van Kerrebroeck PE. Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis. J Urol. 1995;154(1):169\u201373.","journal-title":"J Urol"},{"key":"1339_CR12","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/j.1464-410X.2003.04756.x","volume":"93","author":"IS Shergill","year":"2004","unstructured":"Shergill IS, Arya M, Hamid R, et al. The importance of autonomic dysreflexia to the urologist. BJU Int. 2004;93:923.","journal-title":"BJU Int"},{"issue":"7","key":"1339_CR13","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1177\/1352458506075651","volume":"13","author":"M de S\u00e8ze","year":"2007","unstructured":"de S\u00e8ze M, Ruffion A, Denys P, Joseph PA, Perrouin-Verbe B, GENULF. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler. 2007;13(7):915\u201328.","journal-title":"Mult Scler"},{"issue":"6","key":"1339_CR14","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/JU.0000000000001309","volume":"204","author":"J Tam","year":"2020","unstructured":"Tam J, Gross MD, Cheung A, Melville PM, Kim JM, Weissbart SJ. Fluid intake and urinary symptoms in patients with multiple sclerosis. J Urol. 2020;204(6):1284\u20139.","journal-title":"J Urol"},{"issue":"8","key":"1339_CR15","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1002\/nau.20941","volume":"29","author":"AC L\u00facio","year":"2010","unstructured":"L\u00facio AC, et al. Pelvic floor muscle training in the treatment of lower urinary tract dysfunction in women with multiple sclerosis. Neurourol Urodyn. 2010;29(8):1410\u20133.","journal-title":"Neurourol Urodyn"},{"issue":"18","key":"1339_CR16","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1001\/jama.288.18.2293","volume":"288","author":"KL Burgio","year":"2002","unstructured":"Burgio KL, Goode PS, Locher JL, Umlauf MG, Roth DL, Richter HE, et al. Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: a randomized controlled trial. JAMA. 2002;288(18):2293\u20139.","journal-title":"JAMA"},{"key":"1339_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1308\/003588406X95101","volume":"88","author":"RS Ahluwalia","year":"2006","unstructured":"Ahluwalia RS, Johal N, Kouriefs C, et al. The surgical risk of suprapubic catheter insertion and long-term sequelae. Ann R Coll Surg Engl. 2006;88:210.","journal-title":"Ann R Coll Surg Engl"},{"key":"1339_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S0022-5347(17)47290-9","volume":"134","author":"PE Zimmern","year":"1985","unstructured":"Zimmern PE, Hadley HR, Leach GE, et al. Transvaginal closure of the bladder neck and placement of a suprapubic catheter for destroyed urethra after long-term indwelling catheterization. J Urol. 1985;134:554.","journal-title":"J Urol"},{"key":"1339_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2165\/11597530-000000000-00000","volume":"29","author":"MB Chancellor","year":"2012","unstructured":"Chancellor MB, et al. Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder. Drugs Aging. 2012;29:259\u201373.","journal-title":"Drugs Aging"},{"issue":"10","key":"1339_CR20","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41393-022-00853-3","volume":"60","author":"Y Akkoc","year":"2022","unstructured":"Akkoc Y. Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: a systematic review. Spinal Cord. 2022;60(10):854\u201361.","journal-title":"Spinal Cord"},{"key":"1339_CR21","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41393-022-00766-1","volume":"60","author":"K Matsuda","year":"2022","unstructured":"Matsuda K, Teruya K, Uemura O. Urodynamic effect of vibegron on neurogenic lower urinary tract dysfunction in individuals with spinal cord injury: a retrospective study. Spinal Cord. 2022;60:716\u201321.","journal-title":"Spinal Cord"},{"key":"1339_CR22","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1097\/01.ju.0000084623.65480.f8","volume":"170","author":"P Abrams","year":"2003","unstructured":"Abrams P, Amarenco G, Bakke A, et al. Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury. J Urol. 2003;170:1242.","journal-title":"J Urol"},{"key":"1339_CR23","unstructured":"Stankovich EIu, Borisov VV, Demina TL. Tamsulosin in the treatment of detrusor-sphincter dyssynergia of the urinary bladder in patients with multiple sclerosis. Urologiia. 2004;(4):48\u201351."},{"issue":"1","key":"1339_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0404.2005.00431.x","volume":"112","author":"R Bosma","year":"2005","unstructured":"Bosma R, Wynia K, Havl\u00edkov\u00e1 E, De Keyser J, Middel B. Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis. Acta Neurol Scand. 2005;112(1):1\u20135.","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"1339_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/nau.23921","volume":"38","author":"V Ph\u00e9","year":"2019","unstructured":"Ph\u00e9 V, Schneider MP, Peyronnet B, Abo Youssef N, Mordasini L, Chartier-Kastler E, et al. Desmopressin for treating nocturia in patients with multiple sclerosis: a systematic review. Neurourol Urodyn. 2019;38(2):563\u201371.","journal-title":"Neurourol Urodyn"},{"key":"1339_CR26","unstructured":"Leslie SW, Tadi P, Tayyeb M. Neurogenic bladder and neurogenic lower urinary tract dysfunction [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [updated 2023; cited 2025 Jul 3]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560617\/"},{"issue":"5","key":"1339_CR27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1517\/14740338.2011.579899","volume":"10","author":"P Gerretsen","year":"2011","unstructured":"Gerretsen P, Pollock BG. Drugs with anticholinergic properties: a current perspective on use and safety. Expert Opin Drug Saf. 2011;10(5):751\u201365.","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"1339_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s40261-021-01020-x","volume":"41","author":"MP Rutman","year":"2021","unstructured":"Rutman MP, Horn JR, Newman DK, Stefanacci RG. Overactive bladder prescribing considerations: the role of polypharmacy, anticholinergic burden, and CYP2D6 drug-drug interactions. Clin Drug Investig. 2021;41(4):293\u2013302.","journal-title":"Clin Drug Investig"},{"key":"1339_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/TCRM.S310371","volume":"18","author":"J Frankel","year":"2022","unstructured":"Frankel J, Staskin D, Varano S, Kennelly MJ, Jankowich RA, Haag-Molkenteller C. An evaluation of the efficacy and safety of vibegron in the treatment of overactive bladder. Ther Clin Risk Manag. 2022;18:171\u201382.","journal-title":"Ther Clin Risk Manag"},{"key":"1339_CR30","doi-asserted-by":"publisher","first-page":"592304","DOI":"10.3389\/fneur.2020.592304","volume":"11","author":"AP Sempere","year":"2021","unstructured":"Sempere AP, et al. Ocrelizumab in multiple sclerosis: a real-world study from Spain. Front Neurol. 2021;11:592304.","journal-title":"Front Neurol"},{"key":"1339_CR31","unstructured":"Wu JM, Siddiqui NY, Wiltshire T, Voora D, Schmader K. Can pharmacogenetics be used to predict the response to fesoterodine fumarate? Urogynecology (Phila)."},{"key":"1339_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.5213\/inj.1836118.059","volume":"22","author":"GP Li","year":"2018","unstructured":"Li GP, Wang XY, Zhang Y. Efficacy and safety of onabotulinumtoxinA in patients with neurogenic detrusor overactivity caused by spinal cord injury: a systematic review and meta-analysis. Int Neurourol J. 2018;22:275.","journal-title":"Int Neurourol J"},{"key":"1339_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5213\/inj.1732646.323","volume":"21","author":"H Yuan","year":"2017","unstructured":"Yuan H, Cui Y, Wu J, et al. Efficacy and adverse events associated with use of onabotulinumtoxinA for treatment of neurogenic detrusor overactivity: a meta-analysis. Int Neurourol J. 2017;21:53.","journal-title":"Int Neurourol J"},{"key":"1339_CR34","doi-asserted-by":"publisher","first-page":"e657","DOI":"10.1212\/WNL.0000000000005991","volume":"91","author":"M Tullman","year":"2018","unstructured":"Tullman M, Chartier-Kastler E, Kohan A, et al. Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS. Neurology. 2018;91:e657.","journal-title":"Neurology"},{"key":"1339_CR35","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.eururo.2010.09.024","volume":"58","author":"TM Kessler","year":"2010","unstructured":"Kessler TM, La Framboise D, Trelle S, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol. 2010;58:865.","journal-title":"Eur Urol"},{"key":"1339_CR36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jns.2014.10.010","volume":"347","author":"E Andretta","year":"2014","unstructured":"Andretta E, Simeone C, Ostardo E, et al. Usefulness of sacral nerve modulation in a series of multiple sclerosis patients with bladder dysfunction. J Neurol Sci. 2014;347:257.","journal-title":"J Neurol Sci"},{"key":"1339_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00192-009-1023-6","volume":"21","author":"SP Marinkovic","year":"2010","unstructured":"Marinkovic SP, Gillen LM. Sacral neuromodulation for multiple sclerosis patients with urinary retention and clean intermittent catheterization. Int Urogynecol J. 2010;21:223.","journal-title":"Int Urogynecol J"},{"key":"1339_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12894-015-0102-x","volume":"15","author":"DS Engeler","year":"2015","unstructured":"Engeler DS, Meyer D, Abt D, et al. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series. BMC Urol. 2015;15:105.","journal-title":"BMC Urol"},{"issue":"5","key":"1339_CR39","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/nau.70053","volume":"44","author":"T Cohen","year":"2025","unstructured":"Cohen T, Huang Z, Aalami-Harandi A, Park J, Sbrollini K, Braun N, et al. Revision rates for rechargeable versus non-rechargeable sacral neuromodulation devices in the management of overactive bladder. Neurourol Urodyn. 2025;44(5):1031\u20135.","journal-title":"Neurourol Urodyn"},{"key":"1339_CR40","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00192-015-2814-6","volume":"27","author":"C Zecca","year":"2016","unstructured":"Zecca C, Panicari L, Disanto G, et al. Posterior tibial nerve stimulation in the management of lower urinary tract symptoms in patients with multiple sclerosis. Int Urogynecol J. 2016;27:521.","journal-title":"Int Urogynecol J"},{"key":"1339_CR41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/JU.0000000000001733","volume":"206","author":"A Rogers","year":"2021","unstructured":"Rogers A, Bragg S, Ferrante K, Chuladatta T, Peterson DKL. Pivotal study of leadless tibial nerve stimulation with eCoin\u00ae for urgency urinary incontinence: an open-label, single-arm trial. J Urol. 2021;206:399\u2013408.","journal-title":"J Urol"},{"issue":"3","key":"1339_CR42","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/JU.0000000000004328","volume":"213","author":"JPFA Heesakkers","year":"2025","unstructured":"Heesakkers JPFA, Toozs-Hobson P, Sutherland SE, et al. Two-year efficacy and safety outcomes of the pivotal OASIS study using the Revi System for treatment of urgency urinary incontinence. J Urol. 2025;213(3):323\u201332.","journal-title":"J Urol"},{"issue":"7","key":"1339_CR43","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/nau.23213","volume":"36","author":"V Ph\u00e9","year":"2017","unstructured":"Ph\u00e9 V, Boissier R, Blok BFM, et al. Continent catheterizable tubes\/stomas in adult neuro-urological patients: a systematic review. Neurourol Urodyn. 2017;36(7):1711\u201322.","journal-title":"Neurourol Urodyn"},{"key":"1339_CR44","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/nau.20695","volume":"28","author":"NJ Hellenthal","year":"2009","unstructured":"Hellenthal NJ, Short SS, O\u2019Connor RC, et al. Incontinent ileovesicostomy: long-term outcomes and complications. Neurourol Urodyn. 2009;28:483.","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"1339_CR45","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.urology.2011.06.015","volume":"78","author":"G Legrand","year":"2011","unstructured":"Legrand G, Roupr\u00eat M, Comperat E, Even-Schneider A, Denys P, Chartier-Kastler E. Functional outcomes after management of end-stage neurological bladder dysfunction with ileal conduit in a multiple sclerosis population. Urology. 2011;78(4):937\u201341.","journal-title":"Urology"},{"key":"1339_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1046\/j.1442-2042.2002.00463.x","volume":"9","author":"H Kato","year":"2002","unstructured":"Kato H, Hosaka K, Kobayashi S, et al. Fate of tetraplegic patients managed by ileal conduit for urinary control: long-term follow-up. Int J Urol. 2002;9:253.","journal-title":"Int J Urol"},{"key":"1339_CR47","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1097\/JU.0000000000002235","volume":"206","author":"DA Ginsberg","year":"2021","unstructured":"Ginsberg DA, Boone TB, Cameron AP, et al. The AUA\/SUFU guideline on adult neurogenic lower urinary tract dysfunction: diagnosis and evaluation. J Urol. 2021;206:1097.","journal-title":"J Urol"},{"issue":"7","key":"1339_CR48","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S1474-4422(15)00070-8","volume":"14","author":"JN Panicker","year":"2015","unstructured":"Panicker JN, Fowler CJ, Kessler TM. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol. 2015;14(7):720\u201332.","journal-title":"Lancet Neurol"},{"issue":"4","key":"1339_CR49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5334\/ijic.6473","volume":"22","author":"E Lammila-Escalera","year":"2022","unstructured":"Lammila-Escalera E, Greenfield G, Barber S, Nicholls D, Majeed A, Hayhoe BWJ. A systematic review of interventions that use multidisciplinary team meetings to manage multimorbidity in primary care. Int J Integr Care. 2022;22(4):6.","journal-title":"Int J Integr Care"},{"issue":"1","key":"1339_CR50","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40120-021-00239-2","volume":"10","author":"L Lakin","year":"2021","unstructured":"Lakin L, Davis BE, Binns CC, Currie KM, Rensel MR. Comprehensive approach to management of multiple sclerosis: addressing invisible symptoms\u2014a narrative review. Neurol Ther. 2021;10(1):75\u201398.","journal-title":"Neurol Ther"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-026-01339-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-026-01339-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-026-01339-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:02:09Z","timestamp":1780718529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-026-01339-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1339"],"URL":"https:\/\/doi.org\/10.1007\/s11934-026-01339-y","relation":{},"ISSN":["1534-6285"],"issn-type":[{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}